United States Biotechnology & Medical Research

Editas Medicine Inc (EDIT)

Track

Track

Editas Medicine Inc. experienced five insider trading transactions over the past ninety days, totaling 49,771 USD in sales. Key executives, including the CEO and Chief Scientific Officer, offloaded shares during this period. These divestments occurred following the company's recent earnings report, while the stock price demonstrated a 13.7% increase throughout the last quarter.
Ticker: EDIT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Editas Medicine Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
199.83
Quantity 55,248 +40.2%
Value US$3,674,967
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
59.10
Quantity 91,902 -3.0%
Value US$1,341,725
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
344.29
Quantity 95,807 +42.1%
Value US$1,304,544
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.28
Quantity 1,000
Value US$100,000
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
3.28
Quantity 1,000
Value US$100,000
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.58
Quantity 678 -4.5%
Value US$1,749
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.67
Quantity 4,928 -7.3%
Value US$13,158
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
2.88
Quantity 5,500
Value US$15,840
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.70
Quantity 15,380 -5.8%
Value US$41,543
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.70
Quantity 15,380 -5.8%
Value US$41,543
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.70
Quantity 731 -1.1%
Value US$1,975
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.70
Quantity 464 -3.0%
Value US$1,253
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.08
Quantity 15,000
Value US$46,200
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.02
Quantity 5,394 -2.0%
Value US$10,894
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.02
Quantity 474 -3.0%
Value US$957
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.02
Quantity 749 -1.1%
Value US$1,513
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.89
Quantity 6,000
Value US$11,340
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.15
Quantity 713 -1.0%
Value US$1,535
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.15
Quantity 5,603 -2.0%
Value US$12,064
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.15
Quantity 461 -2.8%
Value US$993
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.50
Quantity 7,000
Value US$17,500
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
2.60
Quantity 710 -1.0%
Value US$1,843
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.60
Quantity 5,592 -2.0%
Value US$14,517
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.60
Quantity 458 -2.7%
Value US$1,189
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.73
Quantity 7,000
Value US$19,110
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
2.73
Quantity 800
Value US$2,184
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.58
Quantity 679 -3.9%
Value US$1,752
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.49
Quantity 5,121 -7.4%
Value US$12,757
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
3.46
Quantity 7,500
Value US$25,950
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
1.72
Quantity 15,192 -5.1%
Value US$26,196
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
1.72
Quantity 726 -1.0%
Value US$1,252
2.1
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
1.72
Quantity 446 -2.5%
Value US$769
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.87
Quantity 20,000
Value US$37,400
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
1.71
Quantity 2,891 -4.0%
Value US$4,946
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
1.71
Quantity 16,632 -5.3%
Value US$28,452
3.6
Lucera Erick EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.71
Quantity 4,109 -3.5%
Value US$7,030
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.86
Quantity 35,000
Value US$65,100
3.6
Lucera Erick Officer Officer
Transaction date
Proposed sale
Price
1.86
Quantity 8,000
Value US$14,880
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
1.86
Quantity 6,000
Value US$11,160
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.08
Quantity 1,618 -0.5%
Value US$3,361
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
2.08
Quantity 541 -0.4%
Value US$1,124
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
3.42
Quantity 518 -0.4%
Value US$1,774
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
3.42
Quantity 1,555 -0.5%
Value US$5,325
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.92
Quantity 3,000
Value US$11,760
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
3.92
Quantity 1,000
Value US$3,920
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
5.42
Quantity 11,886 -14.0%
Value US$64,370
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
5.61
Quantity 26,000
Value US$145,860
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.21
Quantity 6,619 -4.7%
Value US$34,456
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
5.61
Quantity 14,000
Value US$78,540
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.50
Quantity 511 -0.4%
Value US$2,808
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
5.50
Quantity 12,191 -3.7%
Value US$66,997
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.32
Quantity 24,000
Value US$127,680
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
5.32
Quantity 1,000
Value US$5,320
3.6
Lucera Erick EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
5.61
Quantity 22,337 -16.1%
Value US$125,404
3.6
Lucera Erick Officer Officer
Transaction date
Proposed sale
Price
5.71
Quantity 45,000
Value US$256,950
3.2
Hopfield Jessica Non-Executive Director
Transaction date
Purchase
Price
5.64
Quantity 45,000 +198.2%
Value US$253,868
3.2
Hopfield Jessica Non-Executive Director
Transaction date
Purchase
Price
5.64
Quantity 45,000 +198.2%
Value US$253,868
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
9.42
Quantity 77,824 -19.2%
Value US$732,884
4.4
Mei Baisong SVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
9.42
Quantity 20,327 -12.6%
Value US$191,425
4.2
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.86
Quantity 140,000
Value US$1,240,400
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
10.90
Quantity 103 -0.1%
Value US$1,122
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.21
Quantity 695 -0.9%
Value US$5,706
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.40
Quantity 139 -0.2%
Value US$1,168
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.82
Quantity 103 -0.1%
Value US$908
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.59
Quantity 702 -0.9%
Value US$6,033
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.39
Quantity 141 -0.2%
Value US$1,183
4.4
Mei Baisong SVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
8.80
Quantity 4,317 -5.7%
Value US$37,990
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.50
Quantity 105 -0.1%
Value US$998
4.2
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
9.50
Quantity 6,486 -4.7%
Value US$61,638
4.2
Gilmore Neil O'Neill Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.18
Quantity 8,500
Value US$78,030
4.1
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
9.87
Quantity 949 -0.9%
Value US$9,369
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.87
Quantity 668 -0.9%
Value US$6,594
4.1
Michelle Robertson Officer Officer
Transaction date
Proposed sale
Price
3.62
Quantity 3,000
Value US$10,845
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.51
Quantity 135 -0.2%
Value US$1,284
4.1
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
8.89
Quantity 184 -0.2%
Value US$1,636
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
55,248 +40.2%
199.83
US$3,674,967 		55,248 +40.2% 199.83 US$3,674,967
2026-09-04 2026-09-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
91,902 -3.0%
59.10
US$1,341,725 		91,902 -3.0% 59.10 US$1,341,725
2026-09-04 2026-09-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
95,807 +42.1%
344.29
US$1,304,544 		95,807 +42.1% 344.29 US$1,304,544
2026-08-31 2026-09-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
1,000
3.28
US$100,000 		1,000 3.28 US$100,000
2026-08-31 2026-09-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
1,000
3.28
US$100,000 		1,000 3.28 US$100,000
2026-08-05 2026-08-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
678 -4.5%
2.58
US$1,749 		678 -4.5% 2.58 US$1,749
2026-07-29 2026-07-28 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
4,928 -7.3%
2.67
US$13,158 		4,928 -7.3% 2.67 US$13,158
2026-07-21 2026-07-27 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
5,500
2.88
US$15,840 		5,500 2.88 US$15,840
2026-06-05 2026-06-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
15,380 -5.8%
2.70
US$41,543 		15,380 -5.8% 2.70 US$41,543
2026-06-05 2026-06-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
15,380 -5.8%
2.70
US$41,543 		15,380 -5.8% 2.70 US$41,543
2026-06-05 2026-06-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
731 -1.1%
2.70
US$1,975 		731 -1.1% 2.70 US$1,975
2026-06-05 2026-06-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
464 -3.0%
2.70
US$1,253 		464 -3.0% 2.70 US$1,253
2026-05-29 2026-06-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
15,000
3.08
US$46,200 		15,000 3.08 US$46,200
2026-03-04 2026-03-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
5,394 -2.0%
2.02
US$10,894 		5,394 -2.0% 2.02 US$10,894
2026-03-04 2026-03-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
474 -3.0%
2.02
US$957 		474 -3.0% 2.02 US$957
2026-03-04 2026-03-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
749 -1.1%
2.02
US$1,513 		749 -1.1% 2.02 US$1,513
2026-02-27 2026-03-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
6,000
1.89
US$11,340 		6,000 1.89 US$11,340
2025-12-04 2025-12-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
713 -1.0%
2.15
US$1,535 		713 -1.0% 2.15 US$1,535
2025-12-04 2025-12-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
5,603 -2.0%
2.15
US$12,064 		5,603 -2.0% 2.15 US$12,064
2025-12-04 2025-12-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
461 -2.8%
2.15
US$993 		461 -2.8% 2.15 US$993
2025-12-01 2025-12-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
7,000
2.50
US$17,500 		7,000 2.50 US$17,500
2025-09-04 2025-09-03 PlS Planned sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
710 -1.0%
2.60
US$1,843 		710 -1.0% 2.60 US$1,843
2025-09-04 2025-09-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
5,592 -2.0%
2.60
US$14,517 		5,592 -2.0% 2.60 US$14,517
2025-09-04 2025-09-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
458 -2.7%
2.60
US$1,189 		458 -2.7% 2.60 US$1,189
2025-08-29 2025-09-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
7,000
2.73
US$19,110 		7,000 2.73 US$19,110
2025-08-29 2025-09-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
800
2.73
US$2,184 		800 2.73 US$2,184
2025-08-08 2025-08-07 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
679 -3.9%
2.58
US$1,752 		679 -3.9% 2.58 US$1,752
2025-08-04 2025-07-31 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
5,121 -7.4%
2.49
US$12,757 		5,121 -7.4% 2.49 US$12,757
2025-07-30 2025-07-31 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
7,500
3.46
US$25,950 		7,500 3.46 US$25,950
2025-06-04 2025-06-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
15,192 -5.1%
1.72
US$26,196 		15,192 -5.1% 1.72 US$26,196
2025-06-04 2025-06-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
726 -1.0%
1.72
US$1,252 		726 -1.0% 1.72 US$1,252
2025-06-04 2025-06-03 S Sale
2.1
Parison Amy

SVP, Chief Financial Officer

Officer
446 -2.5%
1.72
US$769 		446 -2.5% 1.72 US$769
2025-06-02 2025-06-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
20,000
1.87
US$37,400 		20,000 1.87 US$37,400
2025-03-05 2025-03-04 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
2,891 -4.0%
1.71
US$4,946 		2,891 -4.0% 1.71 US$4,946
2025-03-05 2025-03-04 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
16,632 -5.3%
1.71
US$28,452 		16,632 -5.3% 1.71 US$28,452
2025-03-05 2025-03-04 S Sale
3.6
Lucera Erick

EVP, CHIEF FINANCIAL OFFICER

Officer
4,109 -3.5%
1.71
US$7,030 		4,109 -3.5% 1.71 US$7,030
2025-02-28 2025-03-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
35,000
1.86
US$65,100 		35,000 1.86 US$65,100
2025-02-28 2025-03-03 PrS Proposed sale
3.6
Lucera Erick

Officer

Officer
8,000
1.86
US$14,880 		8,000 1.86 US$14,880
2025-02-28 2025-03-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
6,000
1.86
US$11,160 		6,000 1.86 US$11,160
2024-12-05 2024-12-03 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
1,618 -0.5%
2.08
US$3,361 		1,618 -0.5% 2.08 US$3,361
2024-12-05 2024-12-03 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
541 -0.4%
2.08
US$1,124 		541 -0.4% 2.08 US$1,124
2024-09-06 2024-09-04 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
518 -0.4%
3.42
US$1,774 		518 -0.4% 3.42 US$1,774
2024-09-06 2024-09-04 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
1,555 -0.5%
3.42
US$5,325 		1,555 -0.5% 3.42 US$5,325
2024-08-29 2024-09-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
3,000
3.92
US$11,760 		3,000 3.92 US$11,760
2024-08-29 2024-09-03 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
1,000
3.92
US$3,920 		1,000 3.92 US$3,920
2024-07-26 2024-07-25 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
11,886 -14.0%
5.42
US$64,370 		11,886 -14.0% 5.42 US$64,370
2024-07-18 2024-07-25 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
26,000
5.61
US$145,860 		26,000 5.61 US$145,860
2024-07-22 2024-07-19 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
6,619 -4.7%
5.21
US$34,456 		6,619 -4.7% 5.21 US$34,456
2024-07-18 2024-07-19 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
14,000
5.61
US$78,540 		14,000 5.61 US$78,540
2024-06-06 2024-06-04 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
511 -0.4%
5.50
US$2,808 		511 -0.4% 5.50 US$2,808
2024-06-06 2024-06-04 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
12,191 -3.7%
5.50
US$66,997 		12,191 -3.7% 5.50 US$66,997
2024-05-31 2024-06-03 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
24,000
5.32
US$127,680 		24,000 5.32 US$127,680
2024-05-31 2024-06-03 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
1,000
5.32
US$5,320 		1,000 5.32 US$5,320
2024-05-22 2024-05-20 S Sale
3.6
Lucera Erick

EVP, CHIEF FINANCIAL OFFICER

Officer
22,337 -16.1%
5.61
US$125,404 		22,337 -16.1% 5.61 US$125,404
2024-05-17 2024-05-17 PrS Proposed sale
3.6
Lucera Erick

Officer

Officer
45,000
5.71
US$256,950 		45,000 5.71 US$256,950
2024-05-14 2024-05-13 B Purchase
3.2
Hopfield Jessica
Non-Executive Director
45,000 +198.2%
5.64
US$253,868 		45,000 +198.2% 5.64 US$253,868
2024-05-14 2024-05-13 B Purchase
3.2
Hopfield Jessica
Non-Executive Director
45,000 +198.2%
5.64
US$253,868 		45,000 +198.2% 5.64 US$253,868
2024-03-05 2024-03-05 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
77,824 -19.2%
9.42
US$732,884 		77,824 -19.2% 9.42 US$732,884
2024-03-05 2024-03-04 S Sale
4.4
Mei Baisong

SVP, CHIEF MEDICAL OFFICER

Officer
20,327 -12.6%
9.42
US$191,425 		20,327 -12.6% 9.42 US$191,425
2024-03-04 2024-03-04 PrS Proposed sale
4.2
O'Neill Gilmore Neil

Officer; Director

Executive Director
140,000
8.86
US$1,240,400 		140,000 8.86 US$1,240,400
2023-12-07 2023-12-05 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
103 -0.1%
10.90
US$1,122 		103 -0.1% 10.90 US$1,122
2023-11-16 2023-11-14 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
695 -0.9%
8.21
US$5,706 		695 -0.9% 8.21 US$5,706
2023-11-09 2023-11-07 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
139 -0.2%
8.40
US$1,168 		139 -0.2% 8.40 US$1,168
2023-09-07 2023-09-06 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
103 -0.1%
8.82
US$908 		103 -0.1% 8.82 US$908
2023-08-15 2023-08-11 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
702 -0.9%
8.59
US$6,033 		702 -0.9% 8.59 US$6,033
2023-08-10 2023-08-08 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
141 -0.2%
8.39
US$1,183 		141 -0.2% 8.39 US$1,183
2023-07-21 2023-07-19 S Sale
4.4
Mei Baisong

SVP, CHIEF MEDICAL OFFICER

Officer
4,317 -5.7%
8.80
US$37,990 		4,317 -5.7% 8.80 US$37,990
2023-06-07 2023-06-05 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
105 -0.1%
9.50
US$998 		105 -0.1% 9.50 US$998
2023-06-07 2023-06-05 S Sale
4.2
O'Neill Gilmore Neil

CEO

Executive Director
6,486 -4.7%
9.50
US$61,638 		6,486 -4.7% 9.50 US$61,638
2023-06-02 2023-06-05 PrS Proposed sale
4.2
Gilmore Neil O'Neill

Officer; Director

Executive Director
8,500
9.18
US$78,030 		8,500 9.18 US$78,030
2023-05-15 2023-05-11 S Sale
4.1
ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

Officer
949 -0.9%
9.87
US$9,369 		949 -0.9% 9.87 US$9,369
2023-05-15 2023-05-11 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
668 -0.9%
9.87
US$6,594 		668 -0.9% 9.87 US$6,594
2023-05-11 2023-05-11 PrS Proposed sale
4.1
Michelle Robertson

Officer

Officer
3,000
3.62
US$10,845 		3,000 3.62 US$10,845
2023-05-11 2023-05-09 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
135 -0.2%
9.51
US$1,284 		135 -0.2% 9.51 US$1,284
2023-03-06 2023-03-03 S Sale
4.1
ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

Officer
184 -0.2%
8.89
US$1,636 		184 -0.2% 8.89 US$1,636
Explore more

More insider trading research around Editas Medicine Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America